1. Market Research
  2. > Life Sciences Market Trends
Designs on the Future of Health: The ambitions of Google, Apple, et al

Designs on the Future of Health: The ambitions of Google, Apple, et al

  • March 2016
  • ID: 3841975
  • Format: PDF
  • Firstword Pharma


The digital health revolution: tech giants and their impact on pharma

Drug discovery, quicker clinical trial recruitment, real word data generation, better patient adherence and improved diagnostics/monitoring. Dramatic change is underway as companies such as Google, Apple and Dell expand use of their digital health platforms. What are the organisational/cultural challenges industry must overcome and are tech giants friends or foes?

Designs on the future of Healthcare: the ambitions of Google, Apple et al provides a detailed 360-degree scan of current and upcoming digital technologies and technology players that will radically alter the way pharma conducts its business.

“Technology is forcing us to go beyond how we traditionally do things in terms of healthcare delivery, but also in terms of life sciences development. We are going much faster through the enabling technologies.”

Michael Greenberg, Sanofi Pasteur

Answering key questions:

Why health? Digital health attractedUS$5.8 billion of new investment in 2015 – almost as much as biotech. Why is digital health technology so attractive to investors and tech companies?
Trends: What are the most significant trends affecting healthcare and life sciences?
Who are the Players? Which technology companies are creating innovative digital health solutions and where are the best opportunities for Pharma?
Clinical Trials: How might digital technology be applied to refine and speed up clinical trial recruitment and outcomes assessment?
Patients as Consumers: Consumer technology has opened the door for better engagement with patients. What technologies are being applied now and what applications can be expected?
Apple: Why is Apple’s Research Kit considered ground breaking and how is it being applied?
Cultural challenge: The increased pace of digital advances is impacting traditional pharma. Will tech giants force the industry to change?
Interoperability: Data is locked up in isolated systems. What are the prospects for integrating bioinformatics and clinical informatics data for better clinical and research insights?
Partnering up: What are the essential ingredients for successfully partnering with a digital health technology company?
The Next Five Years: How will digital health technology change healthcare delivery over the next five years and what are the implications for pharma, providers, patients, and payers?

With this report you will be able to:

Understand the digital technologies that are already making an impact and understand which new technologies will bring greater benefits to health providers and industry
Review technology companies such as Apple, Google, IBM, Dell and SAP that are leading the way in digital health and assess their services and ambitions.
Learn from the pharma companies such as Roche, Merck, J&J, Sanofi, and Leo that are actively applying digital health technologies in their business.
Appreciate how digital technology can beneficially modify the way clinical trials are designed, run and followed up.
Assess the need for pharma to fundamentally rethink its practice to fully benefit from digital technology.
Establish the skills needed for successful digital health initiatives.

Key Topics explored

Digital technology holds the prospect of radically reforming Pharma’s operation, but the industry must fundamentally re think its business practice.
Putting together a partnership with a technology giant like Alphabet (Google) - an insider's view
Keys to successful collaboration with technology companies, healthcare CIOs, and patients.
Working models that drive innovation and technological change for pharma and technology companies.
The US healthcare system has created a number of unconnected Electronic Patient Record formats. Can artificial intelligence systems be applied to unlock clinical and research insights for better patient outcomes and research?
What are the challenges of extracting meaningful insights from both structured and unstructured data?
Precision or personalised medicine: what’s the difference?
The empowered tech-savvy patient wants deep, on demand information to help them better manage their health; multichannel communications allows Pharma to engage in a more targeted way.
Digital technology will allow Pharma to benefit from deeper, more granular insights based on genomics to target therapies in unique, and unusual ways.
The application of digital technology in advanced nations is growing rapidly, but what is the situation and challenge in developing it for large-population markets such as China?
Specialist skills in informatics and analytics are essential – Pharma needs to address this talent gap.

Expert Contributors

The report is informed through in-depth interviews with payers, advisors and clinicians. To ensure open and critical responses some contributors identities have been kept anonymous:

Michael Greenberg, MD, MPH, Associate Vice President, Innovation and Patient Centricity, Sanofi Pasteur, FR
Stephane Rouault, Innovation Leader, Global Product Development Medical Affairs, F. Hoffmann-La Roche Ltd., CH
Paul Jacobs, Head of Digital Strategy, LEO Innovation Lab, DK, UK, FR, CA
Joseph Loscalzo, MD, PhD, Hersey Professor of the Theory and Practice of Medicine, Harvard Medical School; Chair, Department of Medicine, Physician-in-Chief, Brigham and Women’s Hospital, US (Also, part of the American Heart Association Partnership with Google.)
Nicholas Genes, MD, PhD, Associate Professor, Icahn School of Medicine at Mount Sinai, US (Also, part of the team for Asthma Health App with Apple ResearchKit.)
Paul Wicks, Vice President of Innovation, PatientsLikeMe, UK
David Chou, Digital Health IT Advisor, dchougroup, US
Dominik Bertram, Head of Healthcare and Life Sciences, SAP Innovation Centre Network, DE
Chris Moose, Partner, IBM Business Consulting Services, US
Nick van Terheyden, MD, Chief Medical Officer, Dell, US
Kors van Wyngaarden, MSc, MD, MBA, Medical Officer Digital Healthcare, Philips, NL
Sarah Jane Militello, Director of Operations, UCSF, Samsung Digital Health Innovation Lab, US
Greg Reh, Global and US Life Sciences Sector Leader, Deloitte Consulting LLP, US
Brett Davis, General Manager (GM) for ConvergeHEALTH by Deloitte, Deloitte Consulting LLP, US
Christopher Zant, Principal, Life Sciences Technology Lead for Digital, Deloitte Consulting LLP, US
Dan Garrett, Partner and Leader PwC, Healthcare IT Practice, US
Digital Leader, Top 20 Pharma

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Survey Management Market Research Report by Type, by Industry, by Deployment, by End User - United States Forecast to 2025 - Cumulative Impact of COVID-19

  • $ 2249
  • January 2021
  • 78 pages

Survey Management Market Research Report by Type (Offline and Online), by Industry (Aerospace & Defense, Automotive & Transportation, Banking, Financial Services & Insurance, Building, Construction & Real ...

  • United States
  • Life Sciences
  • Consumer Goods
  • Industry analysis


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on